| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 06/09/2011 | US20110136729 Occidiofungin, a unique antifungal glycopeptide produced by a strain of burkholderia contaminans |
| 06/09/2011 | US20110136726 Novel antimicrobial agents |
| 06/09/2011 | US20110135687 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 06/09/2011 | US20110135676 Novel antiviral peptide against avian influenza virus h9n2 |
| 06/09/2011 | US20110135675 Melanoma associated peptide analogues and vaccines against melanoma |
| 06/09/2011 | US20110135658 Vhz for diagnosis and treatment of cancers |
| 06/09/2011 | US20110135643 Methods and compositions for prostate cancer immunotherapy |
| 06/09/2011 | US20110135576 Dye conjugates of template-fixed peptidomimetics |
| 06/09/2011 | CA2782484A1 Mybl2 peptides and vaccines containing the same |
| 06/09/2011 | CA2782271A1 Imp-3 oligopeptides and vaccines including the same |
| 06/08/2011 | EP2329814A1 Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer |
| 06/08/2011 | EP2328923A2 Cd133 epitopes |
| 06/08/2011 | EP2328910A2 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 06/08/2011 | EP2328909A1 Human catechol-o-methyltransferase (comt) assay |
| 06/08/2011 | EP2328908A2 Treatment of amyloidoses using myelin basic protein and fragments thereof |
| 06/08/2011 | EP2328611A2 Compositions and methods for treating s.pneumoniae infection |
| 06/08/2011 | EP1919513B1 Targeted vector comprising a cyclodecapeptide RAFT and an activable imaging function |
| 06/08/2011 | CN102089663A Protein disulfide isomerase assay method for the in vitro diagnosis of colorectal cancer |
| 06/08/2011 | CN102089659A Abeta-oligomer measurement method |
| 06/08/2011 | CN102089321A Somatostatin receptor 2 antagonists |
| 06/08/2011 | CN102089320A Lytic domain fusion constructs and methods of making and using same |
| 06/08/2011 | CN102086226A Method for preparing cyclosporine A |
| 06/08/2011 | CN102085362A Polypeptide vaccine for treating diseases caused by highly pathogenic avian influenza viruses H5N1 |
| 06/08/2011 | CN102085354A Polypeptide drug for treating tumors caused by human papilloma virus 16 (HPV-16) |
| 06/08/2011 | CN102085353A Polypeptide drug for treating tumors caused by human papilloma virus 18 (HPV-18) |
| 06/07/2011 | US7956038 GASP1: a follistatin domain containing protein |
| 06/07/2011 | US7956030 Method for reducing pain with ziconotide and baclofen |
| 06/07/2011 | CA2471144C Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate |
| 06/07/2011 | CA2438787C Virus derived antimicrobial peptides |
| 06/03/2011 | WO2011066583A1 Amyloid beta aggregates in cerebro spinal fluid as biomarkers for alzheimer's disease |
| 06/03/2011 | WO2011066521A2 Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same |
| 06/03/2011 | WO2011066386A1 Process for production of degarelix |
| 06/03/2011 | WO2011066285A2 Peptide-based treatment for neurodegenerative diseases |
| 06/03/2011 | WO2011064779A2 PEPTIDES DERIVED FROM HIV-1 gp41 TRANSMEMBRANE DOMAIN AND METHODS OF USE THEREOF |
| 06/03/2011 | WO2011020596A8 Cyclosporine derivatives |
| 06/03/2011 | WO2011003935A9 Parathyroid hormone related protein antagonists |
| 06/03/2011 | CA2781952A1 Amyloid beta aggregates in cerebro spinal fluid as biomarkers for alzheimer's disease |
| 06/02/2011 | US20110131671 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications |
| 06/02/2011 | US20110131669 Ganglioside epitopes for treating guillain-barre syndrome |
| 06/02/2011 | US20110130348 Kinetically efficient substrate for lipoic acid ligase |
| 06/02/2011 | US20110130346 Peptide conjugates for delvery of biologically active compounds |
| 06/02/2011 | US20110130343 Immunity-inducing agent and method for detection of cancer |
| 06/02/2011 | US20110130342 Peptide homing to brain tumors |
| 06/02/2011 | US20110130327 Multi-Arm Amines and Uses Thereof |
| 06/02/2011 | US20110129859 Biomarker for diagnosis of liver disease |
| 06/02/2011 | US20110129611 Decorating hydroxyapatite biomaterials with modular biologically active molecules |
| 06/02/2011 | US20110129483 Membrane transporter NaPi2b (SCL34A1) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy |
| 06/02/2011 | US20110129457 Variant hhip1 protein and methods and uses thereof |
| 06/02/2011 | US20110129418 Brain Tumor Targeting Peptides and Methods |
| 06/02/2011 | US20110129413 Bioconjugation of Calcium Phosphosilicate Nanoparticles For Selective Targeting of Cells In Vivo |
| 06/01/2011 | EP2327714A1 Prophylactic or therapeutic agent for influenza virus infection |
| 06/01/2011 | EP2327713A1 Metal-binding compounds and uses therefor |
| 06/01/2011 | EP2327712A2 Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides |
| 06/01/2011 | EP2326661A1 Synthetic peptides corresponding to overlapping neutralizing determinants in the cbd1 epitope induce broadly neutralizing antibodies. |
| 06/01/2011 | EP2326659A2 Production of infectious hepatitis c virus particles in cell culture |
| 06/01/2011 | CN102084251A Biomarkers for acute coronary disorder |
| 06/01/2011 | CN102083852A Cyclosporin analogs and their use in the treatment of HCV infections |
| 06/01/2011 | CN102083851A Opiorphin peptide derivatives as potent inhibitors of enkephalin - degrading ectopetidases |
| 06/01/2011 | CN102079777A Artificially synthesized antimicrobial peptide, preparation method and application thereof |
| 06/01/2011 | CN101381402B NY-ESO-1 tumour antigen mimic epitope and use thereof |
| 06/01/2011 | CN101362795B Epitope of epididymal protease inhibitor B cell and antigen peptides containing thereof |
| 06/01/2011 | CN101348521B Aminoacid mimic epitope of human B lymphocyte stimulating factor receptor and use thereof |
| 06/01/2011 | CN101336110B Peptide for preventing and treating liver harm, derivative and application thereof |
| 05/31/2011 | US7951925 Using zinc finger protein nuclease as therapeutic tool in treatment and prevention of viral infection |
| 05/31/2011 | US7951911 Carbon nanotube binding peptides |
| 05/31/2011 | US7951909 A polypeptide containing an N-terminal fragment of Amyloid beta (A beta ) peptide linked to a helper T cell epitope (Th) having multiple class II binding motifs; generated antibodies are highly cross-reactive to the soluble A beta 1-42 peptide and the amyloid plaques in the brain |
| 05/31/2011 | US7951906 Compounds capable of interacting with a cell-surface fibroblast growth factor receptor |
| 05/31/2011 | US7951904 Therapeutic uses of monoclonal antibodies to the angiotensin-II type-1 receptor |
| 05/31/2011 | US7951778 Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis |
| 05/31/2011 | US7951775 Methods and pharmaceutical compositions for GnRH-I and GnRH-II modulation of T-cell activity, adhesion, migration and extravasation |
| 05/26/2011 | WO2011063419A2 Lipopeptide compositions and related methods |
| 05/26/2011 | WO2011063367A1 Melanocortin-1 receptor-specific linear peptides |
| 05/26/2011 | WO2011063366A1 Melanocortin-1 receptor-specific cyclic peptides |
| 05/26/2011 | WO2011063133A1 LOW ANTIGEN-DOSE IMMUNIZATION FOR MAXIMIZING T-HELPER CELL 1 (T h1) IMMUNITY AGAINST DISEASE |
| 05/26/2011 | WO2011062560A1 Method for producing t cell receptor-like monoclonal antibodies and uses thereof |
| 05/26/2011 | WO2011060937A1 Template-fixed peptidomimetics with ccr10 antagonistic activty |
| 05/26/2011 | WO2011060832A1 Template-fixed peptidomimetics with ccr10 antagonistic activity |
| 05/26/2011 | WO2011060528A1 Heteropeptides useful for reducing nonspecific adsorption |
| 05/26/2011 | WO2011038397A3 Peptide adjuvants, vaccines, and methods of use |
| 05/26/2011 | WO2011009052A3 Electroactivated peptides and biosensors |
| 05/26/2011 | WO2011008996A3 Peptides whose uptake in cells is controllable |
| 05/26/2011 | US20110126326 Strong activation domain |
| 05/26/2011 | US20110124842 Peptide that binds to a broadly neutralizing anti-HIV antibody-structure of 4E10 Fab fragment complex, uses thereof, compositions therefrom |
| 05/26/2011 | US20110124583 Methods and Compositions for the Treatment of Gastrointestinal Disorders |
| 05/26/2011 | US20110124571 Opiorphin peptide derivatives as potent inhibitors of enkephalin-degrading ectopeptidases |
| 05/26/2011 | US20110124569 Macrocyclic compounds, protease inhibition, and methods of treatment |
| 05/26/2011 | US20110124564 Nucleolin-binding peptides, nucleolin- binding lytic peptides, fusion constructs and methods of making and using same |
| 05/26/2011 | US20110123611 Peptidyl diacylglycerides |
| 05/26/2011 | US20110123537 Binding epitopes for g250 antibody |
| 05/26/2011 | US20110123519 Recombinant antigen |
| 05/26/2011 | US20110123492 Immunity-inducing agent |
| 05/26/2011 | US20110123450 Macrocyclic cyanine and indocyanine bioconjugates provide improved biomedical application |
| 05/26/2011 | CA2817671A1 Heteropeptides useful for reducing nonspecific adsorption |
| 05/26/2011 | CA2781666A1 Lipopeptide compositions and related methods |
| 05/26/2011 | CA2781405A1 Melanocortin-1 receptor-specific linear peptides |
| 05/26/2011 | CA2781402A1 Melanocortin-1 receptor-specific cyclic peptides |
| 05/26/2011 | CA2780949A1 Template-fixed peptidomimetics with ccr10 antagonistic activity |
| 05/26/2011 | CA2780207A1 Low antigen-dose immunization for maximizing t-helper cell 1 (th1) immunity against disease |
| 05/25/2011 | EP2325204A2 Production of motif-specific and context-independent antibodies using peptide libraries as antigens |
| 05/25/2011 | EP2324047A2 Template-fixed peptidomimetics |